Hohl Benjamin — CHIEF FINANCIAL OFFICER
Insider trading activity for Hohl Benjamin sourced from SEC EDGAR Form 4 filings.
Overview
- Title: CHIEF FINANCIAL OFFICER
- Company: Enliven Therapeutics, Inc.
- Total insider trades: 11
- Total buy volume: $0
- Total sell volume: $919K
- Last trade: Sep 21, 2026
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | Hohl Benjamin | ELVN Enliven Therapeutics, Inc. | OTHER | 3,982 | N/A |
| Sep 17, 2026 | Hohl Benjamin | ELVN Enliven Therapeutics, Inc. | SELL | 289 | $15K |
| Sep 17, 2026 | Hohl Benjamin | ELVN Enliven Therapeutics, Inc. | SELL | 2,194 | $111K |
| Sep 17, 2026 | Hohl Benjamin | ELVN Enliven Therapeutics, Inc. | SELL | 3,535 | $177K |
| Sep 17, 2026 | Hohl Benjamin | ELVN Enliven Therapeutics, Inc. | OTHER | 3,982 | $59K |
| Aug 17, 2026 | Hohl Benjamin | EELVN EELVN | SELL | 6,018 | $353K |
| Jun 17, 2026 | Hohl Benjamin | ELVN Enliven Therapeutics, Inc. | OTHER | 6,018 | N/A |
| Jun 17, 2026 | Hohl Benjamin | ELVN Enliven Therapeutics, Inc. | SELL | 1,238 | $55K |
| Jun 17, 2026 | Hohl Benjamin | ELVN Enliven Therapeutics, Inc. | SELL | 3,401 | $149K |
| Jun 17, 2026 | Hohl Benjamin | ELVN Enliven Therapeutics, Inc. | SELL | 1,379 | $59K |
| Jun 17, 2026 | Hohl Benjamin | ELVN Enliven Therapeutics, Inc. | OTHER | 6,018 | $15K |